Rhythm Pharmaceuticals buy Bank of America Co.
Start price
01.08.23
/
50%
€20.80
Target price
01.08.24
-
Performance (%)
97.12%
End price
02.08.24
€41.00
Summary
This prediction ended on 02.08.24 with a price of €41.00. The BUY prediction by Bank_of_America_Co_ for Rhythm Pharmaceuticals saw massive gains of 97.12%. Bank_of_America_Co_ has a follow-up prediction for Rhythm Pharmaceuticals where he still thinks Rhythm Pharmaceuticals is a Buy. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Rhythm Pharmaceuticals | 0.535% | 0.535% | 77.727% |
| iShares Core DAX® | 0.765% | 4.791% | 21.634% |
| iShares Nasdaq 100 | 1.418% | 3.133% | 5.422% |
| iShares Nikkei 225® | 0.658% | 0.972% | 15.333% |
| iShares S&P 500 | 1.310% | 2.279% | 3.125% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Rhythm Pharmaceuticals diskutieren
Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) was upgraded by analysts at Bank of America Co. from a "neutral" rating to a "buy" rating.
Ratings data for RYTM provided by MarketBeat
In the thread Trading Rhythm Pharmaceuticals
Die von Bank_of_America_Co_ gewählte maximale Laufzeit wurde überschritten
Current prediction by Bank_of_America_Co_ for Rhythm Pharmaceuticals
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€50.50
07.04.25
07.04.25
€57.38
07.04.26
07.04.26
89.11%
23.12.25
23.12.25
Stopped prediction by Bank_of_America_Co_ for Rhythm Pharmaceuticals
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€76.50
10.07.25
10.07.25
€80.90
10.07.26
10.07.26
24.84%
23.12.25
23.12.25